These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27839926)

  • 1. National treatment trends among older patients with T1-localized renal cell carcinoma.
    Kim SP; Gross CP; Meropol N; Kutikov A; Smaldone MC; Shah ND; Yu JB; Psutka S; Kiechle J; Abouassaly R
    Urol Oncol; 2017 Mar; 35(3):113.e15-113.e21. PubMed ID: 27839926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the treatment of clinical T1 renal cell carcinoma for octogenarians: Analysis of the National Cancer Database.
    Miller C; Raza SJ; Davaro F; May A; Siddiqui S; Hamilton ZA
    J Geriatr Oncol; 2019 Mar; 10(2):285-291. PubMed ID: 30528544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
    Uhlig A; Uhlig J; Trojan L; Kim HS
    J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.
    Banegas MP; Harlan LC; Mann B; Yabroff KR
    Urol Oncol; 2016 Oct; 34(10):433.e9-433.e17. PubMed ID: 27321355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma.
    Doolittle J; Piotrowski J; Zuk K; Jacobsohn K; Langenstroer P; See W; Johnson S
    Urology; 2019 Oct; 132():136-142. PubMed ID: 31279691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses.
    Liss MA; Wang S; Palazzi K; Jabaji R; Patel N; Lee HJ; Parsons JK; Derweesh IH
    BMC Urol; 2014 Dec; 14():101. PubMed ID: 25519922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004-2013.
    Plante K; Stewart TM; Wang D; Bratslavsky G; Formica M
    Int Urol Nephrol; 2017 Aug; 49(8):1375-1381. PubMed ID: 28550475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort.
    Kim SP; Shah ND; Weight CJ; Thompson RH; Moriarty JP; Shippee ND; Costello BA; Boorjian SA; Leibovich BC
    J Urol; 2011 Nov; 186(5):1779-85. PubMed ID: 21944105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underutilization of partial nephrectomy for stage T1 renal cell carcinoma in the United States, trends from 2000 to 2008. A long way to go.
    Colli J; Sartor O; Grossman L; Lee BR
    Clin Genitourin Cancer; 2012 Dec; 10(4):219-24. PubMed ID: 22749689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older.
    Lane BR; Abouassaly R; Gao T; Weight CJ; Hernandez AV; Larson BT; Kaouk JH; Gill IS; Campbell SC
    Cancer; 2010 Jul; 116(13):3119-26. PubMed ID: 20564627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma.
    Baillargeon-Gagné S; Jeldres C; Lughezzani G; Sun M; Isbarn H; Capitanio U; Shariat SF; Crépel M; Alasker A; Widmer H; Arjane P; Patard JJ; Perrotte P; Montorsi F; Graefen M; Karakiewicz PI
    BJU Int; 2010 Feb; 105(3):359-64. PubMed ID: 20089096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
    Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
    J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age distribution for partial and radical nephrectomy: whose nephrons are being spared?
    von Klot C; Herrmann TR; Wegener G; Kuczyk MA; Hupe MC; Akkoyun M; Peters I; Kramer MW; Merseburger AS
    Adv Ther; 2013 Oct; 30(10):924-32. PubMed ID: 24155056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of surgical approach for the management of renal cell carcinoma: a population-based study from New South Wales.
    Patel MI; Strahan S; Bang A; Vass J; Smith DP
    ANZ J Surg; 2017 Nov; 87(11):E193-E198. PubMed ID: 27283936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
    Choueiri TK; Schutz FA; Hevelone ND; Nguyen PL; Lipsitz SR; Williams SB; Silverman SG; Hu JC
    Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.